PATENT CLAIM ANALYSIS

Application Number: 16004093
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "007920"]

Abstract:
Methods aiding in the diagnosis of certain neuropathies are disclosed, in which the titer of antibodies to a disulfated heparin disaccharide is assessed in a test sample from a subject. Also disclosed are apparatus and kits that can be used in the methods of the invention.

Claim (Index 7):
The kit of  claim 5 , wherein the GM1 ganglioside and the disulfated heparin disaccharide are bound to a solid phase.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.36111
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13393612', '10225474', '10838706', '15527972', '12014948']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6237764879351507
- 35 USC 102 Novelty (BERT): 0.5471636649838131
- Combined Prediction Score: 0.616115205640017
- Mean Citation Score: 269.63392400000004
- Max Citation Score: 494.57855
- Similarity Product: 243.8776496390641

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test